 | • レポートコード：GIR-2104Z12503 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、帯状疱疹ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。帯状疱疹ワクチンの種類別市場規模（Zostavax、Shingrix）、用途別市場規模（50歳以下、50〜60歳、60〜70歳、70歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・帯状疱疹ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、GlaxoSmithKline ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：Zostavax、Shingrix ・用途別分析2016年-2026年：50歳以下、50〜60歳、60〜70歳、70歳以上 ・帯状疱疹ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・帯状疱疹ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・帯状疱疹ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・帯状疱疹ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・帯状疱疹ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Shingles Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Shingles Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Shingles Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Shingles Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Zostavax
Shingrix
Market segment by Application can be divided into
Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old
The key market players for global Shingles Vaccine market are listed below:
Merck
GlaxoSmithKline
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Shingles Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Shingles Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Zostavax
1.2.3 Shingrix
1.3 Market Analysis by Application
1.3.1 Overview: Global Shingles Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Under 50 Years Old
1.3.3 50-60 Years Old
1.3.4 60-70 Years Old
1.3.5 Above 70 Years Old
1.4 Global Shingles Vaccine Market Size & Forecast
1.4.1 Global Shingles Vaccine Sales in Value (2016-2026))
1.4.2 Global Shingles Vaccine Sales in Volume (2016-2026)
1.4.3 Global Shingles Vaccine Price by Type (2016-2026) & (USD/Dose)
1.5 Global Shingles Vaccine Production Capacity Analysis
1.5.1 Global Shingles Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Shingles Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Shingles Vaccine Market Drivers
1.6.2 Shingles Vaccine Market Restraints
1.6.3 Shingles Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Shingles Vaccine Product and Services
2.1.4 Merck Shingles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Shingles Vaccine Product and Services
2.2.4 GlaxoSmithKline Shingles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Shingles Vaccine Sales by Manufacturer
3.1 Global Shingles Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Shingles Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Shingles Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Shingles Vaccine Manufacturer Market Share
3.4.2 Top 6 Shingles Vaccine Manufacturer Market Share
3.5 Global Shingles Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Shingles Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Shingles Vaccine Market Size by Region
4.1.1 Global Shingles Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Shingles Vaccine Revenue by Region (2016-2026)
4.2 North America Shingles Vaccine Revenue (2016-2026)
4.3 Europe Shingles Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Shingles Vaccine Revenue (2016-2026)
4.5 South America Shingles Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Shingles Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Shingles Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Shingles Vaccine Revenue by Type (2016-2026)
5.3 Global Shingles Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Shingles Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Shingles Vaccine Revenue by Application (2016-2026)
6.3 Global Shingles Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Shingles Vaccine Sales by Type (2016-2026)
7.2 North America Shingles Vaccine Sales by Application (2016-2026)
7.3 North America Shingles Vaccine Market Size by Country
7.3.1 North America Shingles Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Shingles Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Shingles Vaccine Sales by Type (2016-2026)
8.2 Europe Shingles Vaccine Sales by Application (2016-2026)
8.3 Europe Shingles Vaccine Market Size by Country
8.3.1 Europe Shingles Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Shingles Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Shingles Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Shingles Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Shingles Vaccine Market Size by Region
9.3.1 Asia-Pacific Shingles Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Shingles Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Shingles Vaccine Sales by Type (2016-2026)
10.2 South America Shingles Vaccine Sales by Application (2016-2026)
10.3 South America Shingles Vaccine Market Size by Country
10.3.1 South America Shingles Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Shingles Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Shingles Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Shingles Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Shingles Vaccine Market Size by Country
11.3.1 Middle East & Africa Shingles Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Shingles Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Shingles Vaccine Typical Distributors
12.3 Shingles Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Shingles Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Shingles Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Shingles Vaccine Product and Services
Table 6. Merck Shingles Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Shingles Vaccine Product and Services
Table 10. GlaxoSmithKline Shingles Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Shingles Vaccine Sales by Manufacturer (2019-2021e) & (K Doses)
Table 12. Global Shingles Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Shingles Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Shingles Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 15. Head Office and Shingles Vaccine Production Site of Key Manufacturer
Table 16. Global Shingles Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 17. Global Shingles Vaccine Sales by Region (2021-2026) & (K Doses)
Table 18. Global Shingles Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Shingles Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Shingles Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 21. Global Shingles Vaccine Sales by Type (2021-2026) & (K Doses)
Table 22. Global Shingles Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Shingles Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Shingles Vaccine Price by Type (2016-2021e) & (USD/Dose)
Table 25. Global Shingles Vaccine Price by Type (2021-2026) & (USD/Dose)
Table 26. Global Shingles Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 27. Global Shingles Vaccine Sales by Application (2021-2026) & (K Doses)
Table 28. Global Shingles Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Shingles Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Shingles Vaccine Price by Application (2016-2021e) & (USD/Dose)
Table 31. Global Shingles Vaccine Price by Application (2021-2026) & (USD/Dose)
Table 32. North America Shingles Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 33. North America Shingles Vaccine Sales by Country (2021-2026) & (K Doses)
Table 34. North America Shingles Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Shingles Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Shingles Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 37. North America Shingles Vaccine Sales by Type (2021-2026) & (K Doses)
Table 38. North America Shingles Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 39. North America Shingles Vaccine Sales by Application (2021-2026) & (K Doses)
Table 40. Europe Shingles Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 41. Europe Shingles Vaccine Sales by Country (2021-2026) & (K Doses)
Table 42. Europe Shingles Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Shingles Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Shingles Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 45. Europe Shingles Vaccine Sales by Type (2021-2026) & (K Doses)
Table 46. Europe Shingles Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 47. Europe Shingles Vaccine Sales by Application (2021-2026) & (K Doses)
Table 48. Asia-Pacific Shingles Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 49. Asia-Pacific Shingles Vaccine Sales by Region (2021-2026) & (K Doses)
Table 50. Asia-Pacific Shingles Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Shingles Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Shingles Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 53. Asia-Pacific Shingles Vaccine Sales by Type (2021-2026) & (K Doses)
Table 54. Asia-Pacific Shingles Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 55. Asia-Pacific Shingles Vaccine Sales by Application (2021-2026) & (K Doses)
Table 56. South America Shingles Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 57. South America Shingles Vaccine Sales by Country (2021-2026) & (K Doses)
Table 58. South America Shingles Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Shingles Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Shingles Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 61. South America Shingles Vaccine Sales by Type (2021-2026) & (K Doses)
Table 62. South America Shingles Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 63. South America Shingles Vaccine Sales by Application (2021-2026) & (K Doses)
Table 64. Middle East & Africa Shingles Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 65. Middle East & Africa Shingles Vaccine Sales by Country (2021-2026) & (K Doses)
Table 66. Middle East & Africa Shingles Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Shingles Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Shingles Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 69. Middle East & Africa Shingles Vaccine Sales by Type (2021-2026) & (K Doses)
Table 70. Middle East & Africa Shingles Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 71. Middle East & Africa Shingles Vaccine Sales by Application (2021-2026) & (K Doses)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Shingles Vaccine Typical Distributors
Table 75. Shingles Vaccine Typical Customers
List of Figures
Figure 1. Shingles Vaccine Picture
Figure 2. Global Shingles Vaccine Sales Market Share by Type in 2020
Figure 3. Zostavax
Figure 4. Shingrix
Figure 5. Global Shingles Vaccine Sales Market Share by Application in 2020
Figure 6. Under 50 Years Old
Figure 7. 50-60 Years Old
Figure 8. 60-70 Years Old
Figure 9. Above 70 Years Old
Figure 10. Global Shingles Vaccine Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 11. Global Shingles Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Shingles Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Shingles Vaccine Sales (2016-2026) & (K Doses)
Figure 32. Global Shingles Vaccine Production Capacity (2016-2026) & (K Doses)
Figure 33. Global Shingles Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Shingles Vaccine Market Drivers
Figure 35. Shingles Vaccine Market Restraints
Figure 36. Shingles Vaccine Market Trends
Figure 37. Global Shingles Vaccine Sales Market Share by Manufacturer in 2020
Figure 38. Global Shingles Vaccine Revenue Market Share by Manufacturer in 2020
Figure 39. Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Shingles Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Shingles Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Shingles Vaccine Sales Market Share by Region (2016-2026)
Figure 43. Global Shingles Vaccine Revenue Market Share by Region (2016-2026)
Figure 44. North America Shingles Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. Europe Shingles Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Shingles Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. South America Shingles Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Shingles Vaccine Revenue (2016-2026) & (USD Million)
Figure 49. Global Shingles Vaccine Sales Market Share by Type (2016-2026)
Figure 50. Global Shingles Vaccine Revenue Market Share by Type (2016-2026)
Figure 51. Global Shingles Vaccine Price by Type (2016-2026) & (USD/Dose)
Figure 52. Global Shingles Vaccine Sales Market Share by Application (2016-2026)
Figure 53. Global Shingles Vaccine Revenue Market Share by Application (2016-2026)
Figure 54. Global Shingles Vaccine Price by Application (2016-2026) & (USD/Dose)
Figure 55. North America Shingles Vaccine Sales Market Share by Country (2016-2026)
Figure 56. North America Shingles Vaccine Revenue Market Share by Country (2016-2026)
Figure 57. North America Shingles Vaccine Sales Market Share by Type (2016-2026)
Figure 58. North America Shingles Vaccine Sales Market Share by Application (2016-2026)
Figure 59. Europe Shingles Vaccine Sales Market Share by Country (2016-2026)
Figure 60. Europe Shingles Vaccine Revenue Market Share by Country (2016-2026)
Figure 61. Europe Shingles Vaccine Sales Market Share by Type (2016-2026)
Figure 62. Europe Shingles Vaccine Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Shingles Vaccine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Shingles Vaccine Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Shingles Vaccine Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Shingles Vaccine Sales Market Share by Application (2016-2026)
Figure 67. South America Shingles Vaccine Sales Market Share by Country (2016-2026)
Figure 68. South America Shingles Vaccine Revenue Market Share by Country (2016-2026)
Figure 69. South America Shingles Vaccine Sales Market Share by Type (2016-2026)
Figure 70. South America Shingles Vaccine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Shingles Vaccine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Shingles Vaccine Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Shingles Vaccine Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Shingles Vaccine Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の帯状疱疹治療市場規模・現状・予測（2021年-2027年） Shingles is a viral disease characterized by a painful skin rash with blisters in a localized area. The shingles treatment market is expected to witness a high growth over the forecast period owing to the increasing prevalence of shingles. Market Analysis and Insights: Global Shingles Treatments Mar…- 世界の成人用ワクチン市場 2021：企業別、地域別、種類・用途別 The Adult Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…
- 世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年） RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, us…
- 世界の食用ワクチン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Edible Vaccine Market The global Edible Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 世界の食用ワクチン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Edible Vaccine Market The global Edible Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…